Funding Obtained: New York's WesperÂ Sleep Therapy Secures $7.5 Million in Series AÂ Investments for Sleep Aid Expansion

Wesper Secures $7.5 Million in Series A Funding for Home-Based Sleep Therapy

Wesper, a revolutionary platform offering customized professional help from sleep specialists during home-based sleep therapy, has secured $7.5 million in Series A funding. The primary investor for this round was Ceros Capital Markets, with Ceros playing a significant role in the funding.

The funding will be used by Wesper to fast-track growth and drive expansion, aiming to improve and expand their sleep therapy services. With this investment, Wesper continues to solidify its position as a leader in the field of sleep therapy.

The Wesper platform is designed to offer continuous measurement and medical diagnosis during the three phases of pre treatment, treatment, and post treatment. It uses sensors and algorithms for accurate medical diagnoses and continuous measurement, providing users with clinical-grade FDA approved full-cycle sleep therapy.

The professionals use the shared data to offer healthcare and develop sleep testing services. Wesper users can receive customized professional help from sleep specialists at home, making sleep therapy more accessible and convenient. The platform also sources out medical diagnoses and provides continuous measurement during home-based sleep therapy.

The goal of Wesper's sleep therapy service is to help users improve their sleep and overall health. By offering continuous measurement and medical diagnosis services, Wesper is committed to providing the best possible care for its users.

Besides Ceros Capital Markets, no other institutions are mentioned as participants in the Series A financing round for Wesper in the provided search results. This investment marks a significant step forward for Wesper, as they continue to innovate and lead the way in home-based sleep therapy.

With the funding, Wesper is well-positioned to expand its services and reach more people in need of sleep therapy. The company is dedicated to making sleep therapy more accessible and affordable, and this investment will help them achieve that goal.

In conclusion, the Series A funding of $7.5 million will enable Wesper to accelerate its growth and expand its sleep therapy services. By offering continuous measurement and medical diagnosis during home-based sleep therapy, Wesper is making sleep therapy more accessible and convenient for users, and helping them improve their sleep and overall health.

Funding Obtained: New York's WesperÂ Sleep Therapy Secures $7.5 Million in Series AÂ Investments for Sleep Aid Expansion